Bernard Mazoyer Selected Research

Bernard Mazoyer Research Topics

4	Dementia (Dementias) 11/2014 - 10/2009
4	Cognitive Dysfunction 04/2012 - 11/2010
3	Cerebral Small Vessel Diseases 01/2020 - 11/2014
3	Stroke (Strokes) 01/2019 - 09/2005
3	Atrophy 10/2015 - 02/2005
2	Dystonia musculorum deformans type 1 12/2021 - 09/2021
2	Dystonia (Limb Dystonia) 12/2021 - 09/2021
2	Schizophrenia (Dementia Praecox) 01/2020 - 11/2010
2	Hypertension (High Blood Pressure) 01/2019 - 01/2009
2	Alzheimer Disease (Alzheimer's Disease) 10/2015 - 01/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2013 - 09/2005
1	Neurodevelopmental Disorders 01/2020
1	Autistic Disorder (Autism) 01/2020
1	Dyslexia (Alexia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Genetic Risk Score 04/2015
1	Brain Infarction 07/2013

6	Apolipoproteins E (ApoE)IBA 04/2015 - 02/2005
3	ApolipoproteinsIBA 03/2011 - 01/2009
2	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 12/2021 - 09/2021
2	Amyloid (Amyloid Fibrils)IBA 10/2015 - 11/2014
1	Cholinergic Agents (Cholinergics)IBA 12/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Temazepam (Nocturne)FDA LinkGeneric 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Second-Generation Antidepressive AgentsIBA 01/2020
1	CholesterolIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	LDL CholesterolIBA 11/2014
1	LipidsIBA 11/2014
1	Triglycerides (Triacylglycerol)IBA 11/2014
1	EnzymesIBA 04/2012
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Perindopril FDA LinkGeneric 09/2005

1	Therapeutics 11/2010